Processa Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Other Income
Processa Pharmaceuticals, Inc. (PCSA) reported Disposal Group, Including Discontinued Operation, Other Income of -$536 for the 9-month period ending 2016-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. disposal group, including discontinued operation, other income for the quarter ending 2016-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. disposal group, including discontinued operation, other income for the quarter ending 2016-06-30 was $3.31K.
| Period end | Disposal Group, Including Discontinued Operation, Other Income 3 month | Disposal Group, Including Discontinued Operation, Other Income 6 month | Disposal Group, Including Discontinued Operation, Other Income 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $3.31K derived: sum of 2 quarters · filed 2017-11-20 | -$536.00 10-Q · filed 2017-11-20 |
| 2016-06-30 | $3.31K 10-Q · filed 2017-10-04 | -$536.00 10-Q · filed 2017-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |